Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05415124 · ClinicalTrials.gov registry record · NA
Presence or Absence of Blood in the GI Lumen
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT05415124 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 15 participants.
The verdict
NCT05415124, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
Bleedings in the upper digestive tract are common. Usually, laboratory and clinical parameters are considered to establish a suspicion for a bleeding in the digestive tract and to estimate urgency of the situation. If these parameters suggest the presence of a bleeding in the digestive tract, endoscopies are often performed to further investigate a patient's status. The above-mentioned laboratory and clinical parameters are sometimes not specific enough to reliably identify a bleeding in the upper digestive tract. The HemoPill acute is capsule device, that has a built in sensor that detects blood in the upper digestive tract. This information is valuable for the medical personnel and complements the information that is obtained from other laboratory or clinical tests
Interventions
- PROCEDURE Endoscopy
- DEVICE HemoPill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-06-17 |
| Est. Completion | 2024-10-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05415124
The ClinicalTrials.gov registry entry for NCT05415124 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Endoscopy is the first listed.
NCT05415124 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05415124 about?
NCT05415124 is a clinical study titled "Presence or Absence of Blood in the GI Lumen". Bleedings in the upper digestive tract are common. Usually, laboratory and clinical parameters are considered to establish a suspicion for a bleeding in the digestive tract and to estimate urgency of the situation. If these parameters suggest the presence of a bleeding in the digestive tract, endosc...
What is the current status of trial NCT05415124?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2022-06-17. Estimated completion is 2024-10-22.
What interventions are being tested in trial NCT05415124?
The interventions under investigation include: Endoscopy (PROCEDURE), HemoPill (DEVICE).
Who is sponsoring clinical trial NCT05415124?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.